Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1399686 in Mild to Moderately Active Ulcerative Colitis
NCT01036022Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 2 trial of GSK1399686 in ulcerative colitis (UC), sponsored by GSK. Started Sep 2009; status: completed.
02
Drugs
GSK1399686
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01036022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01036022.